Microtissues®

Summary

Published in Journal of Mass Spectrometry (2020), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Johnson, Jillian, et al. Sample preparation strategies for high‐throughput mass spectrometry imaging of primary tumor organoids

🧬 Oncology

Sample preparation strategies for high‐throughput mass spectrometry imaging of primary tumor organoids

Journal of Mass Spectrometry 2020 Johnson, Jillian, et al
Cite as: Johnson, Jillian, et al. Sample preparation strategies for high‐throughput mass spectrometry imaging of primary tumor organoids. Journal of Mass Spectrometry (2020). doi:10.1002/jms.4452 doi.org/10.1002/jms.4452

Research Overview

Patient-derived 3D organoids are promising tools for understanding patient heterogeneity and chemotherapy response, and pairing them with mass spectrometry imaging gives a label-free way to characterize drug penetration, patient-specific response, and drug biotransformation. The catch is that the extracellular matrices used to grow tumor organoids generate small-molecule background signal during imaging.

This study developed a method to isolate 3D human tumor organoids from Matrigel into gelatin microarrays compatible with mass spectrometry, enabling high-throughput imaging analysis. Aligning multiple organoids in the same z-axis was essential so they could be sectioned together with reproducible sample preparation on a single slide.

Key Discoveries

  • Method to move tumor organoids out of Matrigel into MS-compatible gelatin microarrays
  • Removes the small-molecule background that ECM produces during mass spectrometry imaging
  • Z-axis alignment of many organoids allows joint sectioning and reproducible high-throughput analysis